Mounjaro milligrams explained: what each strength is for

Why does Mounjaro start at 2.5 mg when the licensed doses go up to 15 mg?

The 2.5 mg pen exists for one reason: to let your digestive system adjust. Tirzepatide slows gastric emptying and amplifies satiety signals through two gut-hormone pathways (GIP and GLP-1) and introducing that effect gradually reduces the nausea, vomiting and stomach discomfort that are most common in the first weeks. At 2.5 mg, most people notice only mild appetite changes. That is by design.

After four weeks on 2.5 mg, a prescriber typically moves the dose to 5 mg. From 5 mg onward, each step up is another 2.5 mg added every four weeks, provided you're tolerating the current strength well. There is no clinical expectation that everyone will reach 15 mg, the right maintenance dose is whichever one produces a meaningful effect at a level of side effects you can live with. Some people find 7.5 mg or 10 mg is their sweet spot.

One practical detail worth knowing: the pen lives in the fridge between doses, but on injection day you can let it reach room temperature first. For precise storage windows, the patient information leaflet is the authority, not an internet summary. The NHS tirzepatide page is a reliable plain-English starting point for storage and administration basics.

What difference does moving up a milligram actually make to weight loss?

The honest answer is that the SURMOUNT-1 trial showed a clear dose-response relationship: higher milligrams produced greater average weight reduction. At 5 mg, participants lost around 15% of body weight on average over 72 weeks. At 10 mg, roughly 19.5%. At 15 mg, the highest dose, the average reached around 20–21%, with some analyses reporting up to 22.5% in certain subgroups. These figures come from SURMOUNT-1, published in the New England Journal of Medicine, and apply to adults with obesity who did not have type 2 diabetes.

What those percentages mean in body weight depends entirely on where you start. A 15% reduction looks very different on someone weighing 90 kg versus 130 kg. The numbers are averages across thousands of participants, your own trajectory is shaped by your metabolism, adherence, dietary habits and how your body responds to the medicine specifically.

Moving up a dose does not guarantee proportionally more weight loss. For some people, 10 mg and 15 mg produce similar results; for others the extra milligrams make a meaningful difference. This is why dose titration is a conversation with a prescriber rather than a straightforward ladder to climb as fast as possible. You can read more about what to expect in the early weeks on our guide to the third week on Mounjaro.

Are side effects worse at higher milligrams?

Generally, yes, the GI side effects that are most common with Mounjaro tend to be more noticeable after dose increases. Nausea, loose stools, constipation, indigestion and burping are the most frequently reported, and most people find they peak in the first few days after stepping up and then settle. The slow titration schedule from 2.5 mg exists precisely to soften this curve.

There are also some less-discussed effects that can appear at any dose and that are worth knowing about before you start. Some people report vivid dreams, which you can read about in our piece on Mounjaro and sleep changes. Others notice headaches, sometimes including migraine-type episodes, our Mounjaro and migraines page covers what the evidence says on that. Fatigue and dizziness can occur too, most often in the first weeks.

Serious but infrequent side effects include acute pancreatitis. Severe, persistent stomach pain that spreads to the back (with or without vomiting) warrants urgent medical attention, not a wait-and-see approach. If you experience a suspected side effect, the MHRA's Yellow Card scheme allows patients to report it directly. Never adjust your dose in response to side effects without speaking to your prescriber first; titration timing is their call, not a self-management decision.

Does the milligram strength affect who can take Mounjaro?

The eligibility threshold is the same regardless of which dose you're on: adults with a BMI of 30 or above, or a BMI of 27 or above alongside at least one weight-related health condition such as high blood pressure, type 2 diabetes, high cholesterol or obstructive sleep apnoea. Lower BMI thresholds can apply for some ethnic backgrounds under UK clinical guidance. BMI alone never settles the question; the prescriber weighs up your full medical picture.

The starting dose is always 2.5 mg. There is no route that begins at a higher strength, however experienced you are with weight-management medicines. If you're transferring from another provider or another medicine, a prescriber will assess your current status before confirming which pen to use next. For a broader overview of how the medicine works and what the licence covers, the Mounjaro treatment page has the detail, and our tirzepatide overview covers the clinical background.

Cost varies between dose strengths. Private prices reflect the pen you're prescribed, not a flat monthly rate, and understanding what's included in any quoted price matters. Our Mounjaro prices guide explains how private treatment is structured and what to look for when comparing providers. If you're ready to find out whether treatment is suitable for you, our prescribers are available seven days a week.